1. Home
  2. CVV vs ALGS Comparison

CVV vs ALGS Comparison

Compare CVV & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CVD Equipment Corporation

CVV

CVD Equipment Corporation

HOLD

Current Price

$4.44

Market Cap

32.5M

Sector

Technology

ML Signal

HOLD

Logo Aligos Therapeutics Inc.

ALGS

Aligos Therapeutics Inc.

HOLD

Current Price

$5.51

Market Cap

34.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVV
ALGS
Founded
1982
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.5M
34.6M
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
CVV
ALGS
Price
$4.44
$5.51
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$39.33
AVG Volume (30 Days)
103.4K
50.8K
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
17.86
88.30
EPS
1.58
N/A
Revenue
$41,128,639.00
$2,186,000.00
Revenue This Year
N/A
$32.20
Revenue Next Year
N/A
$4.71
P/E Ratio
$2.80
N/A
Revenue Growth
96.27
N/A
52 Week Low
$2.96
$3.98
52 Week High
$9.10
$13.69

Technical Indicators

Market Signals
Indicator
CVV
ALGS
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
CVV
ALGS

About CVV CVD Equipment Corporation

CVD Equipment Corp designs, develops, and manufactures a broad range of equipment used to develop and produce materials and coatings for the aerospace, compound semiconductor, semiconductor, aerospace, battery energy storage markets as well as industrial applications, and research. It currently conducts its business through two reportable segments: CVD Equipment, which designs and manufactures chemical vapor deposition, physical vapor transport and thermal process equipment; and SDC, which designs and manufactures ultra-high purity gas and chemical delivery control systems. Its target markets are aerospace & defense and industrial, microelectronics / high power electronics, and EV battery materials / energy storage.

About ALGS Aligos Therapeutics Inc.

Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.

Share on Social Networks: